The Latest Cardiac and Vascular News
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional MedTech services.
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about typical investment sizes in their portfolio companies.
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what he’s expecting to see in the venture capital space in 2023.
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what his team looks for in prospective partners in new venture opportunities.
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about his journey from corporate development to venture capital.
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about how CRG is different from healthcare investment partners in the market.
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.
This week on Investor Insights, host Ken Dropiewski interviews James Eadie, Managing Director of Santé Ventures. They discuss a number of topics including James’s journey into Santé Ventures, Santé’s portfolio, and the working relationship between Santé and early stage companies.
This week on Investor Insights, host Ken Dropiewski interviews Justin Klein, MD, JD and Kirk Nielsen, both Co-Founders and Managing Partners of Vensana Capital. They discuss a number of topics including the future of MedTech, the changes within the industry over the last ten years, and the history of their […]
